Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 9,510.00
+50.00 (0.53%)
Jan 29, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 114.58 billion as of January 29, 2026. Its market cap has increased by 52.41% in one year.
Market Cap
114.58B
Enterprise Value
92.89B
Revenue
884.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
9,510.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 114.58B, an increase of 7.84%. That is a compound annual growth rate of 7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 114.58B | -0.57% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EASY BIO,Inc. | 222.97B |
| Genexine | 221.49B |
| MedPacto | 214.91B |
| Macrogen | 184.74B |
| ENCell | 171.54B |
| GeneOne Life Science | 157.37B |
| IMB Dx | 133.59B |
| iNtRON Biotechnology | 106.37B |